3-[1'(R)-ALPHA-METHYLBENZYL]-4(S)-CHLOROMETHYL-OXAZOLIDIN-2-ONE
- $216 - $499.53
- Product name: 3-[1'(R)-ALPHA-METHYLBENZYL]-4(S)-CHLOROMETHYL-OXAZOLIDIN-2-ONE
- CAS: 444814-24-8
- MF: C12H14ClNO2
- MW: 239.7
- EINECS:
- MDL Number:MFCD03701615
- Synonyms:3-[1'(R)-ALPHA-METHYLBENZYL]-4(S)-CHLOROMETHYL-OXAZOLIDIN-2-ONE;(5R)-5-(Chloromethyl)-3-[(1R)-1-phenylethyl]-2-oxazolidinone];3-(1μ-(R)-α-Methylbenzyl)-4(S)-chloromethyl-oxazolidin-2-one, (S)-5-(Chloromethyl)-3-[(R)-α-methylbenzyl-2-oxazolidinone];(4S)-4-(Chloromethyl)-3-[(1R)-1-phenylethyl]-2-oxazolidinone ;(4S)-4-(Chloromethyl)-3-[(1R)-1-phenylethyl]-2-oxazolidinone 98%;(S)-4-(Chloromethyl)-3-((R)-1-phenylethyl)oxazolidin-2-one;2-Oxazolidinone, 4-(chloromethyl)-3-[(1R)-1-phenylethyl]-, (4S)-
2 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 5MG
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0323172
- Product description(4S)-4-(CHLOROMETHYL)-3-[(1R)-1-PHENYLETHYL]-2-OXAZOLIDINONE 95.00%
- Packaging5MG
- Price$499.53
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product number570605
- Product description(4S)-4-(Chloromethyl)-3-[(1R)-1-phenylethyl]-2-oxazolidinone 98%
- Packaging1g
- Price$216
- Updated2022-05-15
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | HCH0323172 | (4S)-4-(CHLOROMETHYL)-3-[(1R)-1-PHENYLETHYL]-2-OXAZOLIDINONE 95.00% | 5MG | $499.53 | 2021-12-16 | Buy |
Sigma-Aldrich | 570605 | (4S)-4-(Chloromethyl)-3-[(1R)-1-phenylethyl]-2-oxazolidinone 98% | 1g | $216 | 2022-05-15 | Buy |
Properties
Melting point :84-88 °C(lit.)
Boiling point :430.7±28.0 °C(Predicted)
Density :1.227±0.06 g/cm3(Predicted)
pka :-2?+-.0.40(Predicted)
Boiling point :430.7±28.0 °C(Predicted)
Density :1.227±0.06 g/cm3(Predicted)
pka :-2?+-.0.40(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|